2
|
Jafarpour S, Khosravi S, Janghorbani M, Mansourian M, Karimi R, Ghiasi MR, Miraghajani M, Symonds ME, Farajzadeghan Z, Salehi R. Association of serum and follicular fluid leptin and in vitro Fertilization/ ICSI outcome: A systematic review and meta-analysis. J Gynecol Obstet Hum Reprod 2020; 50:101924. [PMID: 33007525 DOI: 10.1016/j.jogoh.2020.101924] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Revised: 09/09/2020] [Accepted: 09/23/2020] [Indexed: 10/23/2022]
Abstract
There are conflicting reports regarding circulating leptin and its relationship between pregnancy outcomes in infertile women undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). We performed a systematic review and meta-analysis to assess the association between serum or follicular fluid (FF) leptin concentrations reported for infertile women and their IVF outcome. A systematic search was undertaken in available databases (PubMed, Scopus, Web of Science, The Cochrane Library and Embase) to find studies published up to Aug 2020 and the standardized mean difference with 95 % confidence interval was taken from 14 eligible studies. Both graphical (funnel plots) and test methods (Egger's regression test and the Begg) assessed the presence of publication bias. Subgroup analysis was used to investigate the source of heterogeneity. Pooled effect sizes based on the eligible papers indicated that of there is no statistically significant correlation between leptin levels in follicular fluid and serum on the day of ovum pick-up (OPU) and day of HCG (human chorionic gonadotrophin) administration in pregnant and non-pregnant women who underwent IVF/ICSI cycles. However, combination of leptin in serum and/or FF with other parameters may be a useful marker to predict IVF outcome.
Collapse
Affiliation(s)
- Sima Jafarpour
- Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-Communicable Diseases Isfahan University of Medical Sciences, Isfahan, Iran
| | - Sharifeh Khosravi
- Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-Communicable Diseases Isfahan University of Medical Sciences, Isfahan, Iran
| | - Mohsen Janghorbani
- Department of Epidemiology and Biostatistics, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Marjan Mansourian
- Department of Epidemiology and Biostatistics, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Raheleh Karimi
- Department of Epidemiology and Biostatistics, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Moosa Rahimi Ghiasi
- Laboratory of Basic Sciences, Mohammad Rasul Allah Research Tower, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Maryam Miraghajani
- Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; The Early Life Research Unit, Academic Division of Child Health, Obstetrics and Gynaecology, and Nottingham Digestive Disease Centre and Biomedical Research Centre, The School of Medicine, University of Nottingham, Nottingham, NG7 2UH, UK
| | - Michael E Symonds
- The Early Life Research Unit, Academic Division of Child Health, Obstetrics and Gynaecology, and Nottingham Digestive Disease Centre and Biomedical Research Centre, The School of Medicine, University of Nottingham, Nottingham, NG7 2UH, UK
| | - Ziba Farajzadeghan
- Department of Community Medicine, Faculty Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Rasoul Salehi
- Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-Communicable Diseases Isfahan University of Medical Sciences, Isfahan, Iran.
| |
Collapse
|
5
|
Cheng L, Shi H, Jin Y, Li X, Pan J, Lai Y, Lin Y, Jin Y, Roy G, Zhao A, Li F. Adiponectin Deficiency Leads to Female Subfertility and Ovarian Dysfunctions in Mice. Endocrinology 2016; 157:4875-4887. [PMID: 27700136 DOI: 10.1210/en.2015-2080] [Citation(s) in RCA: 58] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Adipose tissue plays an important role in regulating female fertility, owing to not only its energy stores but also the endocrine actions of secreted adipokines. As one of the adipokines, adiponectin is almost exclusively secreted from the fat, and its circulating concentration is paradoxically reduced in obesity. Although recent studies implied a purported positive role of adiponectin in ovarian functions, definitive in vivo evidence has been sorely lacking. We have consistently observed subfertility in female adiponectin null mice and therefore postulated a protective role of adiponectin in ovarian functions. Female adiponectin null mice displayed impaired fertility, reduced retrieval of oocytes, disrupted estrous cycle, elevated number of atretic follicles, and impaired late folliculogenesis. Analysis of their sera revealed a significant decrease in estradiol and FSH but an increase in LH and testosterone at proestrus. In addition, we found marked reduction of progesterone levels at diestrus, a significant decrease in LH receptor expression as well as in the number of GnRH immunoreactive neurons. Adiponectin deficiency also altered the peak concentrations of LH surge and led to lower expression of Cytochrome P450 family 11 subfamily A member 1 (P450scc), an enzyme critical for progesterone synthesis, as well as an increase in BCL2 associated X, apoptosis regulator and Insulin like growth factor binding protein 4 in atretic follicles. These physiological and molecular events were independent of insulin sensitivity. Thus, we have revealed a novel mechanism linking adiponectin and female fertility that entails regulation of reproductive hormone balance and ovarian follicle development.
Collapse
Affiliation(s)
- Lixian Cheng
- Collaborative Innovation Center for Cancer Medicine (L.C., A.Z., F.L.), Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong 511495, China; Xiamen Medical College (L.C.), Xiamen, Fujian 361023, China; Department of Pathology (H.S.), Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing, Jiangsu 210029, China; Department of Pathology (Yan Jin), Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; Center of Metabolic Disease Research (X.L., J.P., Y.La., Y.Li.), Nanjing Medical University, Nanjing, Jiangsu 211166, China; and School of Bioscience and Bioengineering (YaJ., G.R.), South China University of Technology, Guangzhou, Guangdong 510006, China
| | - Hui Shi
- Collaborative Innovation Center for Cancer Medicine (L.C., A.Z., F.L.), Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong 511495, China; Xiamen Medical College (L.C.), Xiamen, Fujian 361023, China; Department of Pathology (H.S.), Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing, Jiangsu 210029, China; Department of Pathology (Yan Jin), Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; Center of Metabolic Disease Research (X.L., J.P., Y.La., Y.Li.), Nanjing Medical University, Nanjing, Jiangsu 211166, China; and School of Bioscience and Bioengineering (YaJ., G.R.), South China University of Technology, Guangzhou, Guangdong 510006, China
| | - Yan Jin
- Collaborative Innovation Center for Cancer Medicine (L.C., A.Z., F.L.), Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong 511495, China; Xiamen Medical College (L.C.), Xiamen, Fujian 361023, China; Department of Pathology (H.S.), Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing, Jiangsu 210029, China; Department of Pathology (Yan Jin), Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; Center of Metabolic Disease Research (X.L., J.P., Y.La., Y.Li.), Nanjing Medical University, Nanjing, Jiangsu 211166, China; and School of Bioscience and Bioengineering (YaJ., G.R.), South China University of Technology, Guangzhou, Guangdong 510006, China
| | - Xiaoxi Li
- Collaborative Innovation Center for Cancer Medicine (L.C., A.Z., F.L.), Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong 511495, China; Xiamen Medical College (L.C.), Xiamen, Fujian 361023, China; Department of Pathology (H.S.), Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing, Jiangsu 210029, China; Department of Pathology (Yan Jin), Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; Center of Metabolic Disease Research (X.L., J.P., Y.La., Y.Li.), Nanjing Medical University, Nanjing, Jiangsu 211166, China; and School of Bioscience and Bioengineering (YaJ., G.R.), South China University of Technology, Guangzhou, Guangdong 510006, China
| | - Jinshun Pan
- Collaborative Innovation Center for Cancer Medicine (L.C., A.Z., F.L.), Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong 511495, China; Xiamen Medical College (L.C.), Xiamen, Fujian 361023, China; Department of Pathology (H.S.), Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing, Jiangsu 210029, China; Department of Pathology (Yan Jin), Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; Center of Metabolic Disease Research (X.L., J.P., Y.La., Y.Li.), Nanjing Medical University, Nanjing, Jiangsu 211166, China; and School of Bioscience and Bioengineering (YaJ., G.R.), South China University of Technology, Guangzhou, Guangdong 510006, China
| | - Yimei Lai
- Collaborative Innovation Center for Cancer Medicine (L.C., A.Z., F.L.), Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong 511495, China; Xiamen Medical College (L.C.), Xiamen, Fujian 361023, China; Department of Pathology (H.S.), Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing, Jiangsu 210029, China; Department of Pathology (Yan Jin), Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; Center of Metabolic Disease Research (X.L., J.P., Y.La., Y.Li.), Nanjing Medical University, Nanjing, Jiangsu 211166, China; and School of Bioscience and Bioengineering (YaJ., G.R.), South China University of Technology, Guangzhou, Guangdong 510006, China
| | - Yan Lin
- Collaborative Innovation Center for Cancer Medicine (L.C., A.Z., F.L.), Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong 511495, China; Xiamen Medical College (L.C.), Xiamen, Fujian 361023, China; Department of Pathology (H.S.), Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing, Jiangsu 210029, China; Department of Pathology (Yan Jin), Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; Center of Metabolic Disease Research (X.L., J.P., Y.La., Y.Li.), Nanjing Medical University, Nanjing, Jiangsu 211166, China; and School of Bioscience and Bioengineering (YaJ., G.R.), South China University of Technology, Guangzhou, Guangdong 510006, China
| | - Ya Jin
- Collaborative Innovation Center for Cancer Medicine (L.C., A.Z., F.L.), Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong 511495, China; Xiamen Medical College (L.C.), Xiamen, Fujian 361023, China; Department of Pathology (H.S.), Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing, Jiangsu 210029, China; Department of Pathology (Yan Jin), Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; Center of Metabolic Disease Research (X.L., J.P., Y.La., Y.Li.), Nanjing Medical University, Nanjing, Jiangsu 211166, China; and School of Bioscience and Bioengineering (YaJ., G.R.), South China University of Technology, Guangzhou, Guangdong 510006, China
| | - Gaurab Roy
- Collaborative Innovation Center for Cancer Medicine (L.C., A.Z., F.L.), Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong 511495, China; Xiamen Medical College (L.C.), Xiamen, Fujian 361023, China; Department of Pathology (H.S.), Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing, Jiangsu 210029, China; Department of Pathology (Yan Jin), Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; Center of Metabolic Disease Research (X.L., J.P., Y.La., Y.Li.), Nanjing Medical University, Nanjing, Jiangsu 211166, China; and School of Bioscience and Bioengineering (YaJ., G.R.), South China University of Technology, Guangzhou, Guangdong 510006, China
| | - Allan Zhao
- Collaborative Innovation Center for Cancer Medicine (L.C., A.Z., F.L.), Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong 511495, China; Xiamen Medical College (L.C.), Xiamen, Fujian 361023, China; Department of Pathology (H.S.), Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing, Jiangsu 210029, China; Department of Pathology (Yan Jin), Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; Center of Metabolic Disease Research (X.L., J.P., Y.La., Y.Li.), Nanjing Medical University, Nanjing, Jiangsu 211166, China; and School of Bioscience and Bioengineering (YaJ., G.R.), South China University of Technology, Guangzhou, Guangdong 510006, China
| | - Fanghong Li
- Collaborative Innovation Center for Cancer Medicine (L.C., A.Z., F.L.), Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong 511495, China; Xiamen Medical College (L.C.), Xiamen, Fujian 361023, China; Department of Pathology (H.S.), Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing, Jiangsu 210029, China; Department of Pathology (Yan Jin), Wuxi Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; Center of Metabolic Disease Research (X.L., J.P., Y.La., Y.Li.), Nanjing Medical University, Nanjing, Jiangsu 211166, China; and School of Bioscience and Bioengineering (YaJ., G.R.), South China University of Technology, Guangzhou, Guangdong 510006, China
| |
Collapse
|
6
|
Catteau A, Caillon H, Barrière P, Denis MG, Masson D, Fréour T. Leptin and its potential interest in assisted reproduction cycles. Hum Reprod Update 2015; 22:320-41. [PMID: 26663219 DOI: 10.1093/humupd/dmv057] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2015] [Accepted: 11/17/2015] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Leptin, an adipose hormone, has been shown to control energy homeostasis and food intake, and exert many actions on female reproductive function. Consequently, this adipokine is a pivotal factor in studies conducted on animal models and humans to decipher the mechanisms behind the infertility often observed in obese women. METHODS A systematic PubMed search was conducted on all articles, published up to January 2015 and related to leptin and its actions on energy balance and reproduction, using the following key words: leptin, reproduction, infertility, IVF and controlled ovarian stimulation. The available literature was reviewed in order to provide an overview of the current knowledge on the physiological roles of leptin, its involvement in female reproductive function and its potential interest as a prognostic marker in IVF cycles. RESULTS Animal and human studies show that leptin communicates nutritional status to the central nervous system and emerging evidence has demonstrated that leptin is involved in the control of reproductive functions by acting both directly on the ovaries and indirectly on the central nervous system. With respect to the clinical use of leptin as a biomarker in IVF cycles, a systematic review of the literature suggested its potential interest as a predictor of IVF outcome, as high serum and/or follicular fluid leptin concentrations have correlated negatively with cycle outcome. However, these preliminary results remain to be confirmed. CONCLUSION Leptin regulates energy balance and female reproductive function, mainly through its action on hypothalamic-pituitary-ovarian function, whose molecular and cellular aspects are progressively being deciphered. Preliminary studies evaluating leptin as a biomarker in human IVF seem promising but need further confirmation.
Collapse
Affiliation(s)
- A Catteau
- Service de médecine et biologie du développement et de la reproduction, Hôpital mère et enfant, CHU de Nantes, Nantes, France Faculté de médecine, Université de Nantes, Nantes, France
| | - H Caillon
- Laboratoire de biochimie, Institut de biologie, CHU de Nantes, Nantes, France
| | - P Barrière
- Service de médecine et biologie du développement et de la reproduction, Hôpital mère et enfant, CHU de Nantes, Nantes, France Faculté de médecine, Université de Nantes, Nantes, France INSERM UMR 1064 - ITUN, CHU de Nantes, Nantes, France
| | - M G Denis
- Faculté de médecine, Université de Nantes, Nantes, France Laboratoire de biochimie, Institut de biologie, CHU de Nantes, Nantes, France INSERM UMR 913, Nantes, France
| | - D Masson
- Faculté de médecine, Université de Nantes, Nantes, France Laboratoire de biochimie, Institut de biologie, CHU de Nantes, Nantes, France INSERM UMR 913, Nantes, France
| | - T Fréour
- Service de médecine et biologie du développement et de la reproduction, Hôpital mère et enfant, CHU de Nantes, Nantes, France Faculté de médecine, Université de Nantes, Nantes, France INSERM UMR 1064 - ITUN, CHU de Nantes, Nantes, France Clínica EUGIN, 08029 Barcelona, Spain
| |
Collapse
|